SBI Securities’s AbbVie ABBV Stock Holding History

SBI Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.3M	Sell	58,425 -2,628	-4%	-$674K	0.35%	51
2026 Q2	$15.4M	Sell	61,053 -3,102	-5%	-$667K	0.35%	55
2026 Q1	$13.8M	Buy	64,155 +2,818	+5%	+$625K	0.38%	53
2025 Q4	$14M	Sell	61,337 -844	-1%	-$192K	0.36%	52
2025 Q3	$14.4M	Sell	62,181 -1,883	-3%	-$383K	0.37%	47
2025 Q2	$11.9M	Buy	64,064 +1,063	+2%	+$198K	0.34%	56
2025 Q1	$13.2M	Sell	63,001 -69	-0.1%	-$13.4K	0.44%	46
2024 Q4	$11.2M	Buy	+63,070	New	+$11.6M	0.35%	52

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

SBI Securities's ABBV Position: Q3 2026 in Review

SBI Securities reduced its AbbVie (ABBV) stake by 4.3% in Q3 2026, selling an estimated $674K and leaving 58,425 shares worth $15.3M. The position accounts for 0.35% of the portfolio, ranked #51.

SBI Securities first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $15.4M in Q2 2026. 1,265 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

SBI Securities held 58,425 shares of AbbVie worth $15.3M as of Q3 2026.
SBI Securities sold 2,628 AbbVie shares in Q3 2026, an estimated $674K.
AbbVie made up 0.35% of SBI Securities's portfolio in Q3 2026, its #51 holding.
SBI Securities first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
SBI Securities's AbbVie position peaked at $15.4M in Q2 2026.
1,265 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.